Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

SPOP-Mutated/CHD1-Deleted Lethal Prostate Cancer and Abiraterone Sensitivity.

Boysen G, Rodrigues DN, Rescigno P, Seed G, Dolling D, Riisnaes R, Crespo M, Zafeiriou Z, Sumanasuriya S, Bianchini D, Hunt J, Moloney D, Perez-Lopez R, Tunariu N, Miranda S, Figueiredo I, Ferreira A, Christova R, Gil V, Aziz S, Bertan C, de Oliveira FM, Atkin M, Clarke M, Goodall J, Sharp A, MacDonald T, Rubin MA, Yuan W, Barbieri CE, Carreira S, Mateo J, de Bono JS.

Clin Cancer Res. 2018 Nov 15;24(22):5585-5593. doi: 10.1158/1078-0432.CCR-18-0937. Epub 2018 Aug 1.

PMID:
30068710
2.

Plasma Cell-free DNA Concentration and Outcomes from Taxane Therapy in Metastatic Castration-resistant Prostate Cancer from Two Phase III Trials (FIRSTANA and PROSELICA).

Mehra N, Dolling D, Sumanasuriya S, Christova R, Pope L, Carreira S, Seed G, Yuan W, Goodall J, Hall E, Flohr P, Boysen G, Bianchini D, Sartor O, Eisenberger MA, Fizazi K, Oudard S, Chadjaa M, Macé S, de Bono JS.

Eur Urol. 2018 Sep;74(3):283-291. doi: 10.1016/j.eururo.2018.02.013. Epub 2018 Feb 28.

3.

Synthesis and antiproliferative properties of new hydrophilic esters of triterpenic acids.

Eignerova B, Tichy M, Krasulova J, Kvasnica M, Rarova L, Christova R, Urban M, Bednarczyk-Cwynar B, Hajduch M, Sarek J.

Eur J Med Chem. 2017 Nov 10;140:403-420. doi: 10.1016/j.ejmech.2017.09.041. Epub 2017 Sep 21.

PMID:
28987603
4.

CHD1 loss sensitizes prostate cancer to DNA damaging therapy by promoting error-prone double-strand break repair.

Shenoy TR, Boysen G, Wang MY, Xu QZ, Guo W, Koh FM, Wang C, Zhang LZ, Wang Y, Gil V, Aziz S, Christova R, Rodrigues DN, Crespo M, Rescigno P, Tunariu N, Riisnaes R, Zafeiriou Z, Flohr P, Yuan W, Knight E, Swain A, Ramalho-Santos M, Xu DY, de Bono J, Wu H.

Ann Oncol. 2017 Jul 1;28(7):1495-1507. doi: 10.1093/annonc/mdx165.

5.

Targeting the SIN3A-PF1 interaction inhibits epithelial to mesenchymal transition and maintenance of a stem cell phenotype in triple negative breast cancer.

Bansal N, Petrie K, Christova R, Chung CY, Leibovitch BA, Howell L, Gil V, Sbirkov Y, Lee E, Wexler J, Ariztia EV, Sharma R, Zhu J, Bernstein E, Zhou MM, Zelent A, Farias E, Waxman S.

Oncotarget. 2015 Oct 27;6(33):34087-105. doi: 10.18632/oncotarget.6048.

6.

Selective Inhibition of SIN3 Corepressor with Avermectins as a Novel Therapeutic Strategy in Triple-Negative Breast Cancer.

Kwon YJ, Petrie K, Leibovitch BA, Zeng L, Mezei M, Howell L, Gil V, Christova R, Bansal N, Yang S, Sharma R, Ariztia EV, Frankum J, Brough R, Sbirkov Y, Ashworth A, Lord CJ, Zelent A, Farias E, Zhou MM, Waxman S.

Mol Cancer Ther. 2015 Aug;14(8):1824-36. doi: 10.1158/1535-7163.MCT-14-0980-T. Epub 2015 Jun 15.

7.

Detecting DNA-protein interactions in living cells--ChIP approach.

Christova R.

Adv Protein Chem Struct Biol. 2013;91:101-33. doi: 10.1016/B978-0-12-411637-5.00004-4. Review.

PMID:
23790212
8.

CTCF binds to sites in the major histocompatibility complex that are rapidly reconfigured in response to interferon-gamma.

Ottaviani D, Lever E, Mao S, Christova R, Ogunkolade BW, Jones TA, Szary J, Aarum J, Mumin MA, Pieri CA, Krawetz SA, Sheer D.

Nucleic Acids Res. 2012 Jul;40(12):5262-70. doi: 10.1093/nar/gks158. Epub 2012 Feb 25.

9.

[Agenesis of corpus callosum - a review].

Christova R.

Akush Ginekol (Sofiia). 2010;49(3):29-36. Review. Bulgarian.

PMID:
20734653
10.

[Therapeutic approach in pregnant women with an autoimmune thrombocytopenic purpura].

Christova R, Lisichkov T, Chernev T.

Akush Ginekol (Sofiia). 2009;48(6):53-4. Bulgarian.

PMID:
20225499
11.

[Autoimmune thrombocitopenic purpura in pregnancy].

Christova R, Lisichkov T, Chernev T.

Akush Ginekol (Sofiia). 2009;48(6):42-6. Bulgarian.

PMID:
20225496
12.

Reconfiguration of genomic anchors upon transcriptional activation of the human major histocompatibility complex.

Ottaviani D, Lever E, Mitter R, Jones T, Forshew T, Christova R, Tomazou EM, Rakyan VK, Krawetz SA, Platts AE, Segarane B, Beck S, Sheer D.

Genome Res. 2008 Nov;18(11):1778-86. doi: 10.1101/gr.082313.108. Epub 2008 Oct 10.

13.

P-STAT1 mediates higher-order chromatin remodelling of the human MHC in response to IFNgamma.

Christova R, Jones T, Wu PJ, Bolzer A, Costa-Pereira AP, Watling D, Kerr IM, Sheer D.

J Cell Sci. 2007 Sep 15;120(Pt 18):3262-70. Epub 2007 Aug 28.

14.

Role of antioxidant enzymes in survival of conidiospores of Aspergillus niger 26 under conditions of temperature stress.

Abrashev R, Dolashka P, Christova R, Stefanova L, Angelova M.

J Appl Microbiol. 2005;99(4):902-9.

15.

Association of human TFIID-promoter complexes with silenced mitotic chromatin in vivo.

Christova R, Oelgeschläger T.

Nat Cell Biol. 2002 Jan;4(1):79-82.

PMID:
11744923
16.

Sequences of DNA fragments contacting the nuclear lamina in vivo.

Christova R, Bach I, Galcheva-Gargova Z.

DNA Cell Biol. 1992 Oct;11(8):627-36.

PMID:
1339329
17.

A simple method for isolation of DNA fragments associated with the nuclear lamina in vivo.

Christova R, Galcheva-Gargova Z.

J Biochem Biophys Methods. 1990 Jan;20(2):107-11.

PMID:
2313033
18.

Some features of DNA fragments associated in vivo with the nuclear lamina.

Christova R, Yaneva J, Galcheva-Gargova Z.

Biosci Rep. 1989 Oct;9(5):587-92.

PMID:
2804260

Supplemental Content

Loading ...
Support Center